课题基金 / 基金详情

CARDIOVASCULAR CONSEQUENCES OF SLEEP APNEA

CARDIOVASCULAR CONSEQUENCES OF SLEEP APNEA
睡眠呼吸暂停对心血管的影响
批准号:
2232079
负责人:
Eyal Shahar
金额:
$37.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-30 至 1999-08-31

项目摘要

项目成果

Eyal Shahar的其他基金

相似基金

相关文献

中文摘要
翻译
积累的数据表明,睡眠呼吸暂停和较温和的睡眠形式- 与呼吸相关的疾病(SRBD)可能在 心血管疾病。然而,证据远远不是决定性的, 主要依靠SRBD替代措施和病例对照设计。这个 该项目的总体目标是前瞻性地调查 心血管疾病中的SRBD,采用多中心队列设计。 作为社区动脉粥样硬化风险(ARIC)研究的一部分, 动脉粥样硬化与心血管疾病的人群队列研究 在疾病方面,申请者招募并检查了4009名男性和女性 来自明尼阿波利斯郊区1987-1989年间。参与者接受了第二次 1990-1992年的考试,目前正在进行第三次考试 (1993-1995)。已为1996-1998年的第四次考试提供了资金。范围广泛的 生活方式、生化、生理和临床特征 包括颈动脉内膜中层厚度,a 衡量早期动脉粥样硬化的指标。队列被跟踪的是 动脉粥样硬化进展与心血管终点。所有这些都是 ARIC明尼阿波利斯的特点使其适合于多中心 睡眠研究。 这个项目有五个具体目标。首先,申请者将 通过邮寄问卷的方式,对3828名2级考试归国人员进行筛查,以确定 与SRBD相关的特征,如习惯性鼾声、观察到的呼吸暂停、 白天昏昏欲睡。第二,1000个同意的个人的子集- 500名男性和500名女性-没有临床心血管疾病-将 招募参加家庭通宵睡眠研究以获得呼吸暂停-低呼吸暂停 得分。为了增加研究的统计力量,样本将是 通过过度抽样习惯性打鼾者,增加了患有SRBD的个体。 第三,共有250名参与者(估计有200名检测呈阳性) SRBD和50项测试阴性)将在睡眠中接受多导睡眠监测 实验室:1)验证诊断,2)更好地量化SRBD,3) 计算家庭研究的灵敏度和特异度。第四,在 05年,申请者将对具体的假设进行横截面测试 与:1)SRBD和无症状颈动脉粥样硬化有关;2) SRBD与血压;3)SRBD与激素替代治疗 治疗;4)SRBD和认知功能;5)习惯性打鼾症和 无症状性颈动脉粥样硬化;6)习惯性打鼾症 心血管疾病。第五个也是长期的目标是测试, 充分的随访,SRBD是否与动脉粥样硬化相关 病情进展与随后的心血管疾病风险有关。 拟议的项目具有以下优势:1)拥有一个多学科团队 经验丰富的心血管流行病学家、睡眠研究人员和 生物统计学家,以及2)已经建立的基于人群的队列 具有高应答率和详细的心血管风险测量 因素、早期动脉粥样硬化和心血管疾病终点。它 因此,这将是一项具有成本效益的重要贡献 多中心睡眠研究。
英文摘要
Accumulated data suggest that sleep apnea and milder forms of sleep- related breathing disorders (SRBD) may have an etiologic role in cardiovascular disease. The evidence, however, is far from conclusive, relying mostly on surrogate measures of SRBD and case-control designs. The broad goal of this project is to investigate, prospectively, the role of SRBD in cardiovascular disease, employing a multi-center cohort design. As part of the Atherosclerosis Risk in Communities (ARIC) Study, a population-based cohort study of atherosclerosis and cardiovascular disease, the applicants have recruited and examined 4,009 men and women from suburban Minneapolis in 1987-1989. Participants underwent a second exam in 1990-1992 and are currently being examined for the third time (1993-1995). A fourth exam in 1996-1998 has been funded. A wide range of lifestyle, biochemical, physiological, and clinical characteristics has been measured, including carotid artery intimal-medial thickness, a measure of early atherosclerosis. The cohort is followed for atherosclerosis progression and cardiovascular endpoints. All of these features make the ARIC Minneapolis cohort suitable for the multi-center Sleep Study. There are five specific aims for this project. First, the applicants will screen the 3,828 exam 2 returnees, by means of a mailed questionnaire, for SRBD-associated characteristics such as habitual snoring, observed apnea, and daytime somnolence. Second, a subset of 1,000 consenting individuals - 500 men and 500 women free of clinical cardiovascular disease - will be recruited for a home overnight Sleep Study to derive an apnea-hypopnea score. To increase the study's statistical power, the sample will be enriched with individuals having SRBD by over-sampling habitual snorers. Third, a total of 250 participants (an estimated 200 testing positive for SRBD and 50 testing negative) will undergo polysomnography in a Sleep Laboratory to: 1) validate the diagnosis, 2) better quantify SRBD, and 3) calculate the sensitivity and specificity of the home study. Fourth, in year 05, the applicants will test, cross-sectionally, specific hypotheses related to: 1) SRBD and asymptomatic carotid artery atherosclerosis; 2) SRBD and blood pressure; 3) SRBD and the use of hormone-replacement therapy; 4) SRBD and cognitive function; 5) habitual snoring and asymptomatic carotid atherosclerosis; 6) habitual snoring and prevalent cardiovascular disease. The fifth and long-term aim is to test, with adequate follow-up, whether SRBD is associated with atherosclerosis progression and with subsequent risk of cardiovascular disease. The proposed project has the advantages of 1) a multidisciplinary team of experienced cardiovascular epidemiologists, sleep researchers, and biostatisticians, and 2) an already established population-based cohort with high response rate and detailed measurements of cardiovascular risk factors, early atherosclerosis, and cardiovascular disease endpoints. It will, therefore, be an important and cost-efficient contribution to the multi-center Sleep Study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COMMUNITY SURVEILLANCE OF CONGESTIVE HEART FAILURE
  • 批准号:
    6185034
  • 项目类别:
  • 资助金额:
    $13.64万
  • 财政年份:
    1998
  • 负责人:
    Eyal Shahar
  • 依托单位:
COMMUNITY SURVEILLANCE OF CONGESTIVE HEART FAILURE
  • 批准号:
    6390045
  • 项目类别:
  • 资助金额:
    $38.76万
  • 财政年份:
    1998
  • 负责人:
    Eyal Shahar
  • 依托单位:
COMMUNITY SURVEILLANCE OF CONGESTIVE HEART FAILURE
  • 批准号:
    6537451
  • 项目类别:
  • 资助金额:
    $37.32万
  • 财政年份:
    1998
  • 负责人:
    Eyal Shahar
  • 依托单位:
COMMUNITY SURVEILLANCE OF CONGESTIVE HEART FAILURE
  • 批准号:
    6030926
  • 项目类别:
  • 资助金额:
    $36.82万
  • 财政年份:
    1998
  • 负责人:
    Eyal Shahar
  • 依托单位:
国内基金
海外基金
Accretion variability and its consequences: from protostars to planet-forming disks
  • 批准号:
    12173003
  • 项目类别:
    面上项目
  • 资助金额:
    60万元
  • 批准年份:
    2021
  • 负责人:
    沈雷歌
  • 依托单位:
Exposing Verifiable Consequences of the Emergence of Mass
  • 批准号:
    12135007
  • 项目类别:
    重点项目
  • 资助金额:
    313万元
  • 批准年份:
    2021
  • 负责人:
    Craig Darrian Roberts
  • 依托单位:
Consequences of MALT1 mutation for B cell tolerance
  • 批准号:
    32100719
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    James Qun Wang
  • 依托单位: